Our study demonstrates that UBA3 is highly expressed in ICC, and UBA3 affects ANXA2 through the MAPK signaling pathway to promote ICC proliferation, invasion and migration. Here, ANXA2 is linked to intrahepatic cholangiocarcinoma.